home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Breast Cancer Goes NUMB

 
  January, 9 2008 22:37
your information resource in human molecular genetics
 
     
A protein called NUMB has a crucial role in keeping breast cancer at bay. New research in Nature shows how this protein acts to preserve the function of p53, another protein that is known to protect against cancer.

It is already known that many cases of breast cancer are characterized by the loss of the NUMB protein, which normally functions to help determine how different cell types develop. Now, researchers led by Pier Paolo Di Fiore describe how NUMB helps to stave off cancer by binding to p53 and a third protein, HDM2, which usually degrades p53 and prevents its cancer-busting activity.

By protecting p53 in this way, NUMB is itself acting as an anti-cancer protein, say the researchers, who made their discovery by studying a range of different cells in the test tube, including human breast cells. This is highlighted by the fact that cancers that feature abnormally low levels of NUMB tend to be particularly aggressive, they add.

CONTACT

Pier Paolo Di Fiore (The FIRC Institute for Molecular Oncology, Milan, Italy)
E-mail: pierpaolo.difiore@ifom-ieo-campus.it

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.